
Colossal Biosciences Hits $10.2B Valuation, Targets Mammoth, Dodo Revival
A $10.2B valuation fuels Colossal Biosciences’ bold quest to revive the woolly mammoth, thylacine, and dodo. Could cutting-edge genetic tech reshape species extinction? Learn the timeline and science.